A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.
about
Autoimmune cytopenias in chronic lymphocytic leukemia, facts and mythsIdentification of a 20-gene expression-based risk score as a predictor of clinical outcome in chronic lymphocytic leukemia patients.LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia.The gene expression response of chronic lymphocytic leukemia cells to IL-4 is specific, depends on ZAP-70 status and is differentially affected by an NFκB inhibitor.IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaMiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes.RNA-based markers as prognostic factors in chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance.Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia.
P2860
Q33412266-51C667BF-9FBC-42F9-A91F-A6C9B419EB00Q33634389-4F5EFFE7-63E4-4463-8FC6-BA721784003DQ35143479-02EE3CBB-FC2E-42D4-A217-D1184A017399Q35299464-44677A77-AB19-4DAB-8BEE-DD9C18C7AC0CQ35613623-8C8AC34A-C7C7-429F-BC27-A35090DFC562Q35707206-BE435026-2897-4D25-B7BB-93FBEA29A183Q35889836-C88226D5-0A56-46B5-9687-A5B3EEAA76FAQ36579130-CF76663C-264D-40F0-A17F-7FA9EEEDB577Q37978344-DE0437F5-719D-49C1-8B8D-14A5E112394CQ38088354-4CDC6880-84B4-4C76-9EE4-6C675975A171Q38797069-B956CA06-E037-42D9-9055-A41EF8C982E1Q42426152-0CDC9043-9D8A-44F2-9AF8-513739D4775AQ47105863-5ED94C25-DCDA-462C-AA47-E762231C4B89Q53098391-73CB7922-37C1-459C-8DFC-D2C657488E15Q54319044-A9D477EA-966D-4331-BB64-DB562ED660DA
P2860
A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A molecular score by quantitat ...... lymphocytic leukemia patients.
@ast
A molecular score by quantitat ...... lymphocytic leukemia patients.
@en
type
label
A molecular score by quantitat ...... lymphocytic leukemia patients.
@ast
A molecular score by quantitat ...... lymphocytic leukemia patients.
@en
prefLabel
A molecular score by quantitat ...... lymphocytic leukemia patients.
@ast
A molecular score by quantitat ...... lymphocytic leukemia patients.
@en
P2093
P2860
P1433
P1476
A molecular score by quantitat ...... lymphocytic leukemia patients.
@en
P2093
Basile Stamatopoulos
Cécile De Bruyn
Dominique Bron
Géraldine Anthoine
Karlien Pieters
Laurence Lagneaux
Nathalie Meuleman
Philippe Mineur
P2860
P304
P356
10.1371/JOURNAL.PONE.0012780
P407
P577
2010-09-16T00:00:00Z